Cancer treatment has entered a new era where "one-size-fits-all" no longer applies. Personalized medicine uses genetic testing to understand a patient’s specific cancer type, enabling doctors to craft targeted therapies that are often more effective and less toxic. Treatments like immunotherapy and gene editing tools such as CRISPR are revolutionizing oncology. As more research unfolds, the hope is to make these advanced treatments more accessible and affordable. This article explores how this shift is improving survival rates and transforming cancer care, while also addressing the challenges of cost, data privacy, and healthcare infrastructure.